Copyright
©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 843-859
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.843
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.843
Ref. | Year | Countries | Patients | OBI prevalence, n (%) | Types of studies | Methods | DNA low limit of detection | Effective | HBV genotype |
Abdel-Maksoud et al[104] | 2019 | Egypt | Haemodialysis | 7.3 | Cohort | Nested PCR | 30 copies/mL | 150 | |
Elbedewy et al[114] | 2015 | Egypt | Patient with malignant tumors of the lymphatic system | 13.89 | Cross-sectional | Real-time PCR | 12 IU/mL | 72 | |
Kishk et al[58] | 2015 | Egypt | Blood donors | 22.7 | ND | Real-time PCR | 100 copies/mL | 343 | D |
Elrashidy et al[20] | 2014 | Egypt | Diabetic children and adolescents following hepatitis B vaccination | 0 | ND | Nested PCR | 100 copies/mL | 170 | |
El-Ghitany et al[86] | 2013 | Egypt | Blood donors with hepatitis C | 4,16 (3,2 HVC+ et 5,1 HCV-) | Case–control study | Real time PCR | 45 copies/mL | 504 | |
Elkady et al[113] | 2013 | Egypt | Hematological malignant patients | 5.66 | ND | Real-time PCR | 20 IU/mL | 18 | D1 |
Said et al[48] | 2013 | Egypt | Blood donors | 1.64 | Cross-sectional | Real-time PCR | 3.8 IU/mL | 3167 | |
Abu El Makarem et al[105] | 2012 | Egypt | Haemodialysis with/without HCV | 4.1 | ND | Real-time PCR | 6 IU/mL | 145 | |
Selim et al[89] | 2011 | Egypt | HCV patients | 38.3 | ND | Real-time PCR | 45 copies/mL | 60 | |
Emara et al[90] | 2010 | Egypt | HCV patients | 3.9 | Cross-sectional | Real-Time PCR | 12 IU/mL | 155 | |
El-Sherif et al[91] | 2009 | Egypt | HCV patients | 16 | ND | Real-Time PCR | 30 copies/mL | 100 | |
Gissa et al[99] | 2022 | Ethiopia | Patients with chronic liver disease of unidentified cause | 5.56 | Prospective | Real-Time PCR | 15 IU/mL | 36 | |
Bivigou-Mboumba et al[75] | 2018 | Gabon | HIV patient | 17.5 | Cross-sectional | Real-time PCR | 50 IU/mL | 137 | |
Bivigou-Mboumba et al[76] | 2016 | Gabon | HIV patient | 8 | Cross-sectional | Real-time PCR | 100 IU/mL | 762 | A E |
Ndow et al[27] | 2022 | Gambia | General population | 18.3 | Case-control study | Nested PCR | 5 IU/mL | 82 | |
Attiku et al[77] | 2021 | Ghana | HIV/HBV co-infected patients | 30.8 | Longitudinal purposive study | Real-time PCR | 2 copies/mL | 13 | |
Attia et al[78] | 2012 | Ivory Coast | HIV patient | 21.3 | Cross-sectional | COBAS Amplicor HBV | 6 UI/mL | 188 | |
Salyani et al[70] | 2021 | Kenya | HIV patient ART naïve | 5.3 | Cross-sectional | COBAS AmpliPrep | 20 UI/mL | 208 | |
Mabunda et al[51] | 2020 | Mozambique | Blood donors | 0.98 | Cross-sectional | PCR | 20 UI/mL | 1435 | |
Fasola et al[60] | 2021 | Nigeria | Blood donors | 1 | Cross-sectional | Nested PCR | 1 IU/mL | 100 | |
Olotu et al[53] | 2016 | Nigeria | Blood donors | 5.4 | Cross-sectional | Real-time PCR | 20 IU/mL | 354 | |
Powell et al[81] | 2015 | South Africa | HIV patient | 13.5 | ND | Real-time PCR | 250 copies/mL | 394 | |
Hoffmann et al[65] | 2014 | South Africa | Pregnant women with HIV | 1.71 | Case-control study | Real-time PCR | 20 IU/ mL | 175 | |
Bell et al[68] | 2012 | South Africa | ART naive HIV | 3.79 | Cohort | Real-time PCR | 20 IU/ mL | 79 |
- Citation: Bazie MM, Sanou M, Djigma FW, Compaore TR, Obiri-Yeboah D, Kabamba B, Nagalo BM, Simpore J, Ouédraogo R. Genetic diversity and occult hepatitis B infection in Africa: A comprehensive review. World J Hepatol 2024; 16(5): 843-859
- URL: https://www.wjgnet.com/1948-5182/full/v16/i5/843.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i5.843